Matinas BioPharma Holdings (MTNB) Debt Ratio (2015)
Matinas BioPharma Holdings (MTNB) posted quarterly Debt Ratio of 0.07 for Q2 2015, down 17.4% quarter-over-quarter from 0.09 in Q1 2015.
Matinas BioPharma Holdings (MTNB) Debt Ratio (2015) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported Debt Ratio for 1 consecutive years, with 0.07 the latest figure, recorded in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 0.47 |
| 10 | Matinas BioPharma Holdings | 1.28 Mn | 470,238.22 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 0.07 |
| Mar 31, 2015 | 0.09 |